Athira Pharma, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Athira Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q3 2022.
  • Athira Pharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was $985K, a 1249% increase year-over-year.
  • Athira Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was $1.75M, a 468% increase year-over-year.
  • Athira Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $334K.
  • Athira Pharma, Inc. annual Nonoperating Income (Expense) for 2020 was -$1.28M, a 175% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $1.75M $985K +$912K +1249% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $842K $493K +$419K +566% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $423K $173K +$89K +106% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $334K $103K +$25K +32.1% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-28
Q3 2021 $309K $73K +$1.13M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$823K $74K -$186K -71.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$637K $84K +$644K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$1.28M $78K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$1.06M -$1.06M -21280% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $260K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$560K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 $5K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.